Drugs / Recombine Endostatin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01689558 | Dec 2011 → Jan 2015 | nasopharyngeal carcinoma | Jin Feng | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombine Endostatin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01689558 ↗ |
| Route | Intravenous | “intravenous drip” NCT01689558 ↗ |